dacarbazine has been researched along with lewis x antigen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, LS; Dawar, R; Dinand, V; Malik, A; Pandey, RM; Unni, R | 1 |
| Classen, CF; Linnebacher, M; Schneider, B; Walther, M; William, D | 1 |
2 other study(ies) available for dacarbazine and lewis x antigen
| Article | Year |
|---|---|
Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Growth Processes; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Immunophenotyping; Kaplan-Meier Estimate; Ki-67 Antigen; Lewis X Antigen; Male; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Tumor Suppressor Protein p53; Vinblastine; Vincristine | 2008 |
Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxycycline; Drug Resistance, Neoplasm; Fucosyltransferases; Glioblastoma; Humans; Lewis X Antigen; Mitochondria; Neoplastic Stem Cells; Nestin; Temozolomide; Tumor Stem Cell Assay; Tumor Suppressor Proteins | 2018 |